Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Cash-and-Short-Term-Investments" stands at 8.91 Billion Euros as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Cash and Short Term Investments" stands at 8.91 Billion EUR. This represents a decrease of -42.01 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 31.07 percent compared to the value the year prior.
The 1 year change in percent is 31.07.
The 3 year change in percent is 29.09.
The 5 year change in percent is -44.23.
The 10 year change in percent is 80.76.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Short Term Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Short Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Short Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Short Term Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Short Term Investments | 280,205,508,085.11 |